{
 "nodes": [
 {
 "id": "Amino acid transport across the plasma membrane",
"label": "Amino acid transport across the plasma membrane",
"size": 60.32484,
"color": "#FF0000",
"x": -1.316276,
"y": 1.240792 
},
{
 "id": "Amino acid transport defects (IEMs)",
"label": "Amino acid transport defects (IEMs)",
"size": 67.15094,
"color": "#FF0700",
"x": -0.9175556,
"y": 1.572206 
},
{
 "id": "Transcription/Translation",
"label": "Transcription/Translation",
"size": 68.30612,
"color": "#FF0E00",
"x": -0.4646028,
"y":   1.6002 
},
{
 "id": "Na+/Cl- dependent neurotransmitter transporters",
"label": "Na+/Cl- dependent neurotransmitter transporters",
"size": 57.14013,
"color": "#FF1500",
"x":   -1.453,
"y": 0.930008 
},
{
 "id": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"label": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"size":  40.2549,
"color": "#FF1C00",
"x": -2.442159,
"y":  2.50799 
},
{
 "id": "Amino acid metabolism",
"label": "Amino acid metabolism",
"size": 24.49533,
"color": "#FF2200",
"x": -7.224939,
"y": -1.85219 
},
{
 "id": "SLC-mediated transmembrane transport",
"label": "SLC-mediated transmembrane transport",
"size": 19.44737,
"color": "#FF2900",
"x": -4.039973,
"y": 3.803954 
},
{
 "id": "Transport of bile salts and organic acids, metal ions and amine compounds",
"label": "Transport of bile salts and organic acids, metal ions and amine compounds",
"size": 29.80965,
"color": "#FF3000",
"x": -3.081237,
"y": 2.568056 
},
{
 "id": "Transport of small molecules",
"label": "Transport of small molecules",
"size":  15.2549,
"color": "#FF3700",
"x": -3.59506,
"y": 4.103158 
},
{
 "id": "Cytosolic tRNA aminoacylation",
"label": "Cytosolic tRNA aminoacylation",
"size": 29.23457,
"color": "#FF3E00",
"x": 0.03176588,
"y": 3.675672 
},
{
 "id": "tRNA Aminoacylation",
"label": "tRNA Aminoacylation",
"size": 29.23457,
"color": "#FF4500",
"x": 0.5655746,
"y": 3.429577 
},
{
 "id": "Mitochondrial tRNA aminoacylation",
"label": "Mitochondrial tRNA aminoacylation",
"size": 29.23457,
"color": "#FF4C00",
"x": -0.4550847,
"y": 3.840805 
},
{
 "id": "Metabolism of amino acids and derivatives",
"label": "Metabolism of amino acids and derivatives",
"size": 12.35252,
"color": "#FF5300",
"x": -7.680789,
"y": 3.094025 
},
{
 "id": "Variant SLC6A14 may confer susceptibility towards obesity",
"label": "Variant SLC6A14 may confer susceptibility towards obesity",
"size": 77.82993,
"color": "#FF5A00",
"x": -1.168509,
"y": 0.9457275 
},
{
 "id": "SLC transporter disorders",
"label": "SLC transporter disorders",
"size": 24.65605,
"color": "#FF6000",
"x": -2.896704,
"y": 3.188207 
},
{
 "id": "Translation",
"label": "Translation",
"size": 23.88452,
"color": "#FF6700",
"x": 0.5973019,
"y": 4.249124 
},
{
 "id": "Defective SLC6A19 causes Hartnup disorder (HND)",
"label": "Defective SLC6A19 causes Hartnup disorder (HND)",
"size":   81.125,
"color": "#FF6E00",
"x": -0.9803761,
"y": 1.143706 
},
{
 "id": "Disorders of transmembrane transporters",
"label": "Disorders of transmembrane transporters",
"size": 20.68991,
"color": "#FF7500",
"x": -4.256535,
"y": 3.312902 
},
{
 "id": "Biochemical pathways: part I",
"label": "Biochemical pathways: part I",
"size": 8.949657,
"color": "#FF7C00",
"x": -3.340431,
"y": -5.320299 
},
{
 "id": "Glucose homeostasis",
"label": "Glucose homeostasis",
"size": 51.54369,
"color": "#FF8300",
"x": -7.874953,
"y": 0.3984852 
},
{
 "id": "Tryptophan catabolism",
"label": "Tryptophan catabolism",
"size": 36.95062,
"color": "#FF8A00",
"x": -5.809416,
"y": -3.812183 
},
{
 "id": "Amikacin Action Pathway",
"label": "Amikacin Action Pathway",
"size": 56.89222,
"color": "#FF9100",
"x": -0.1814751,
"y": -0.07980578 
},
{
 "id": "Arbekacin Action Pathway",
"label": "Arbekacin Action Pathway",
"size": 56.89222,
"color": "#FF9800",
"x": -0.0300259,
"y": 0.9574968 
},
{
 "id": "Azithromycin Action Pathway",
"label": "Azithromycin Action Pathway",
"size": 56.89222,
"color": "#FF9F00",
"x": -0.6275775,
"y": -0.04351672 
},
{
 "id": "Chloramphenicol Action Pathway",
"label": "Chloramphenicol Action Pathway",
"size": 56.89222,
"color": "#FFA500",
"x": -0.1961793,
"y": 0.7222035 
},
{
 "id": "Clarithromycin Action Pathway",
"label": "Clarithromycin Action Pathway",
"size": 56.89222,
"color": "#FFAC00",
"x": -0.8223257,
"y": 0.5038546 
},
{
 "id": "Clindamycin Action Pathway",
"label": "Clindamycin Action Pathway",
"size": 56.89222,
"color": "#FFB300",
"x": -0.437765,
"y": 1.200969 
},
{
 "id": "Clomocycline Action Pathway",
"label": "Clomocycline Action Pathway",
"size": 56.89222,
"color": "#FFBA00",
"x": -0.1806022,
"y": 1.126063 
},
{
 "id": "Demeclocycline Action Pathway",
"label": "Demeclocycline Action Pathway",
"size": 56.89222,
"color": "#FFC100",
"x": -1.042264,
"y": -0.1112768 
},
{
 "id": "Doxycycline Action Pathway",
"label": "Doxycycline Action Pathway",
"size": 56.89222,
"color": "#FFC800",
"x": -0.5846559,
"y": 0.2535197 
},
{
 "id": "Erythromycin Action Pathway",
"label": "Erythromycin Action Pathway",
"size": 56.89222,
"color": "#FFCF00",
"x": -0.199634,
"y": 0.3130175 
},
{
 "id": "Gentamicin Action Pathway",
"label": "Gentamicin Action Pathway",
"size": 56.89222,
"color": "#FFD600",
"x": -0.813514,
"y": -0.193805 
},
{
 "id": "Josamycin Action Pathway",
"label": "Josamycin Action Pathway",
"size": 56.89222,
"color": "#FFDD00",
"x": -1.254009,
"y": 0.2466079 
},
{
 "id": "Kanamycin Action Pathway",
"label": "Kanamycin Action Pathway",
"size": 56.89222,
"color": "#FFE300",
"x": -1.074693,
"y": 0.6642345 
},
{
 "id": "Lincomycin Action Pathway",
"label": "Lincomycin Action Pathway",
"size": 56.89222,
"color": "#FFEA00",
"x": -0.5743357,
"y": 0.7118552 
},
{
 "id": "Lymecycline Action Pathway",
"label": "Lymecycline Action Pathway",
"size": 56.89222,
"color": "#FFF100",
"x": -1.433268,
"y": 0.3763894 
},
{
 "id": "Methacycline Action Pathway",
"label": "Methacycline Action Pathway",
"size": 56.89222,
"color": "#FFF800",
"x": -0.3588876,
"y": 0.08466401 
},
{
 "id": "Minocycline Action Pathway",
"label": "Minocycline Action Pathway",
"size": 56.89222,
"color": "#FFFF00",
"x": -0.8170675,
"y": 0.852045 
},
{
 "id": "Neomycin Action Pathway",
"label": "Neomycin Action Pathway",
"size": 56.89222,
"color": "#FFFF0B",
"x": -0.8476125,
"y": 0.1200201 
},
{
 "id": "Netilmicin Action Pathway",
"label": "Netilmicin Action Pathway",
"size": 56.89222,
"color": "#FFFF20",
"x": -1.328693,
"y": 0.5939468 
},
{
 "id": "Oxytetracycline Action Pathway",
"label": "Oxytetracycline Action Pathway",
"size": 56.89222,
"color": "#FFFF35",
"x": -0.005191539,
"y": 0.1320946 
},
{
 "id": "Paromomycin Action Pathway",
"label": "Paromomycin Action Pathway",
"size": 56.89222,
"color": "#FFFF4A",
"x": -0.6904087,
"y": 1.122582 
},
{
 "id": "Rolitetracycline Action Pathway",
"label": "Rolitetracycline Action Pathway",
"size": 56.89222,
"color": "#FFFF60",
"x": -1.250251,
"y": 0.02033638 
},
{
 "id": "Roxithromycin Action Pathway",
"label": "Roxithromycin Action Pathway",
"size": 56.89222,
"color": "#FFFF75",
"x": -1.020546,
"y": 0.3236567 
},
{
 "id": "Spectinomycin Action Pathway",
"label": "Spectinomycin Action Pathway",
"size": 56.89222,
"color": "#FFFF8A",
"x": -0.4641348,
"y": -0.2266263 
},
{
 "id": "Streptomycin Action Pathway",
"label": "Streptomycin Action Pathway",
"size": 56.89222,
"color": "#FFFF9F",
"x": 0.01997808,
"y": 0.5462367 
},
{
 "id": "Telithromycin Action Pathway",
"label": "Telithromycin Action Pathway",
"size": 56.89222,
"color": "#FFFFB5",
"x": -0.4125209,
"y": 0.926739 
},
{
 "id": "Tetracycline Action Pathway",
"label": "Tetracycline Action Pathway",
"size": 56.89222,
"color": "#FFFFCA",
"x": 0.1295557,
"y": 0.7659891 
},
{
 "id": "Tigecycline Action Pathway",
"label": "Tigecycline Action Pathway",
"size": 56.89222,
"color": "#FFFFDF",
"x": -0.3822457,
"y": 0.501601 
},
{
 "id": "Tobramycin Action Pathway",
"label": "Tobramycin Action Pathway",
"size": 56.89222,
"color": "#FFFFF4",
"x": 0.120103,
"y": 0.3605617 
} 
],
"edges": [ {
 "id": "1",
"source": "Amino acid transport across the plasma membrane",
"target": "Amino acid transport defects (IEMs)" 
},
{
 "id": "2",
"source": "Amino acid transport across the plasma membrane",
"target": "Transcription/Translation" 
},
{
 "id": "3",
"source": "Amino acid transport defects (IEMs)",
"target": "Transcription/Translation" 
},
{
 "id": "4",
"source": "Amino acid transport across the plasma membrane",
"target": "Na+/Cl- dependent neurotransmitter transporters" 
},
{
 "id": "5",
"source": "Amino acid transport defects (IEMs)",
"target": "Na+/Cl- dependent neurotransmitter transporters" 
},
{
 "id": "6",
"source": "Transcription/Translation",
"target": "Na+/Cl- dependent neurotransmitter transporters" 
},
{
 "id": "7",
"source": "Amino acid transport across the plasma membrane",
"target": "Transport of inorganic cations/anions and amino acids/oligopeptides" 
},
{
 "id": "8",
"source": "Amino acid transport defects (IEMs)",
"target": "Transport of inorganic cations/anions and amino acids/oligopeptides" 
},
{
 "id": "9",
"source": "Transcription/Translation",
"target": "Transport of inorganic cations/anions and amino acids/oligopeptides" 
},
{
 "id": "10",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Transport of inorganic cations/anions and amino acids/oligopeptides" 
},
{
 "id": "11",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "SLC-mediated transmembrane transport" 
},
{
 "id": "12",
"source": "Amino acid transport across the plasma membrane",
"target": "Transport of bile salts and organic acids, metal ions and amine compounds" 
},
{
 "id": "13",
"source": "Amino acid transport defects (IEMs)",
"target": "Transport of bile salts and organic acids, metal ions and amine compounds" 
},
{
 "id": "14",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Transport of bile salts and organic acids, metal ions and amine compounds" 
},
{
 "id": "15",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "Transport of bile salts and organic acids, metal ions and amine compounds" 
},
{
 "id": "16",
"source": "SLC-mediated transmembrane transport",
"target": "Transport of bile salts and organic acids, metal ions and amine compounds" 
},
{
 "id": "17",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "Transport of small molecules" 
},
{
 "id": "18",
"source": "SLC-mediated transmembrane transport",
"target": "Transport of small molecules" 
},
{
 "id": "19",
"source": "Transport of bile salts and organic acids, metal ions and amine compounds",
"target": "Transport of small molecules" 
},
{
 "id": "20",
"source": "Amino acid transport defects (IEMs)",
"target": "Cytosolic tRNA aminoacylation" 
},
{
 "id": "21",
"source": "Transcription/Translation",
"target": "Cytosolic tRNA aminoacylation" 
},
{
 "id": "22",
"source": "Amino acid transport defects (IEMs)",
"target": "tRNA Aminoacylation" 
},
{
 "id": "23",
"source": "Transcription/Translation",
"target": "tRNA Aminoacylation" 
},
{
 "id": "24",
"source": "Cytosolic tRNA aminoacylation",
"target": "tRNA Aminoacylation" 
},
{
 "id": "25",
"source": "Amino acid transport defects (IEMs)",
"target": "Mitochondrial tRNA aminoacylation" 
},
{
 "id": "26",
"source": "Transcription/Translation",
"target": "Mitochondrial tRNA aminoacylation" 
},
{
 "id": "27",
"source": "Cytosolic tRNA aminoacylation",
"target": "Mitochondrial tRNA aminoacylation" 
},
{
 "id": "28",
"source": "tRNA Aminoacylation",
"target": "Mitochondrial tRNA aminoacylation" 
},
{
 "id": "29",
"source": "Amino acid transport across the plasma membrane",
"target": "Variant SLC6A14 may confer susceptibility towards obesity" 
},
{
 "id": "30",
"source": "Amino acid transport defects (IEMs)",
"target": "Variant SLC6A14 may confer susceptibility towards obesity" 
},
{
 "id": "31",
"source": "Transcription/Translation",
"target": "Variant SLC6A14 may confer susceptibility towards obesity" 
},
{
 "id": "32",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Variant SLC6A14 may confer susceptibility towards obesity" 
},
{
 "id": "33",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "Variant SLC6A14 may confer susceptibility towards obesity" 
},
{
 "id": "34",
"source": "Amino acid transport across the plasma membrane",
"target": "SLC transporter disorders" 
},
{
 "id": "35",
"source": "Amino acid transport defects (IEMs)",
"target": "SLC transporter disorders" 
},
{
 "id": "36",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "SLC transporter disorders" 
},
{
 "id": "37",
"source": "SLC-mediated transmembrane transport",
"target": "SLC transporter disorders" 
},
{
 "id": "38",
"source": "Transport of bile salts and organic acids, metal ions and amine compounds",
"target": "SLC transporter disorders" 
},
{
 "id": "39",
"source": "Transport of small molecules",
"target": "SLC transporter disorders" 
},
{
 "id": "40",
"source": "Transcription/Translation",
"target": "Translation" 
},
{
 "id": "41",
"source": "Cytosolic tRNA aminoacylation",
"target": "Translation" 
},
{
 "id": "42",
"source": "tRNA Aminoacylation",
"target": "Translation" 
},
{
 "id": "43",
"source": "Mitochondrial tRNA aminoacylation",
"target": "Translation" 
},
{
 "id": "44",
"source": "Amino acid transport across the plasma membrane",
"target": "Defective SLC6A19 causes Hartnup disorder (HND)" 
},
{
 "id": "45",
"source": "Amino acid transport defects (IEMs)",
"target": "Defective SLC6A19 causes Hartnup disorder (HND)" 
},
{
 "id": "46",
"source": "Transcription/Translation",
"target": "Defective SLC6A19 causes Hartnup disorder (HND)" 
},
{
 "id": "47",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Defective SLC6A19 causes Hartnup disorder (HND)" 
},
{
 "id": "48",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "Defective SLC6A19 causes Hartnup disorder (HND)" 
},
{
 "id": "49",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Defective SLC6A19 causes Hartnup disorder (HND)" 
},
{
 "id": "50",
"source": "Transport of inorganic cations/anions and amino acids/oligopeptides",
"target": "Disorders of transmembrane transporters" 
},
{
 "id": "51",
"source": "SLC-mediated transmembrane transport",
"target": "Disorders of transmembrane transporters" 
},
{
 "id": "52",
"source": "Transport of bile salts and organic acids, metal ions and amine compounds",
"target": "Disorders of transmembrane transporters" 
},
{
 "id": "53",
"source": "Transport of small molecules",
"target": "Disorders of transmembrane transporters" 
},
{
 "id": "54",
"source": "SLC transporter disorders",
"target": "Disorders of transmembrane transporters" 
},
{
 "id": "55",
"source": "Amino acid transport across the plasma membrane",
"target": "Amikacin Action Pathway" 
},
{
 "id": "56",
"source": "Amino acid transport defects (IEMs)",
"target": "Amikacin Action Pathway" 
},
{
 "id": "57",
"source": "Transcription/Translation",
"target": "Amikacin Action Pathway" 
},
{
 "id": "58",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Amikacin Action Pathway" 
},
{
 "id": "59",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Amikacin Action Pathway" 
},
{
 "id": "60",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Amikacin Action Pathway" 
},
{
 "id": "61",
"source": "Amino acid transport across the plasma membrane",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "62",
"source": "Amino acid transport defects (IEMs)",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "63",
"source": "Transcription/Translation",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "64",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "65",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "66",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "67",
"source": "Amikacin Action Pathway",
"target": "Arbekacin Action Pathway" 
},
{
 "id": "68",
"source": "Amino acid transport across the plasma membrane",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "69",
"source": "Amino acid transport defects (IEMs)",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "70",
"source": "Transcription/Translation",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "71",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "72",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "73",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "74",
"source": "Amikacin Action Pathway",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "75",
"source": "Arbekacin Action Pathway",
"target": "Azithromycin Action Pathway" 
},
{
 "id": "76",
"source": "Amino acid transport across the plasma membrane",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "77",
"source": "Amino acid transport defects (IEMs)",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "78",
"source": "Transcription/Translation",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "79",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "80",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "81",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "82",
"source": "Amikacin Action Pathway",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "83",
"source": "Arbekacin Action Pathway",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "84",
"source": "Azithromycin Action Pathway",
"target": "Chloramphenicol Action Pathway" 
},
{
 "id": "85",
"source": "Amino acid transport across the plasma membrane",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "86",
"source": "Amino acid transport defects (IEMs)",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "87",
"source": "Transcription/Translation",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "88",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "89",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "90",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "91",
"source": "Amikacin Action Pathway",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "92",
"source": "Arbekacin Action Pathway",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "93",
"source": "Azithromycin Action Pathway",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "94",
"source": "Chloramphenicol Action Pathway",
"target": "Clarithromycin Action Pathway" 
},
{
 "id": "95",
"source": "Amino acid transport across the plasma membrane",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "96",
"source": "Amino acid transport defects (IEMs)",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "97",
"source": "Transcription/Translation",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "98",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "99",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "100",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "101",
"source": "Amikacin Action Pathway",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "102",
"source": "Arbekacin Action Pathway",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "103",
"source": "Azithromycin Action Pathway",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "104",
"source": "Chloramphenicol Action Pathway",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "105",
"source": "Clarithromycin Action Pathway",
"target": "Clindamycin Action Pathway" 
},
{
 "id": "106",
"source": "Amino acid transport across the plasma membrane",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "107",
"source": "Amino acid transport defects (IEMs)",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "108",
"source": "Transcription/Translation",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "109",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "110",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "111",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "112",
"source": "Amikacin Action Pathway",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "113",
"source": "Arbekacin Action Pathway",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "114",
"source": "Azithromycin Action Pathway",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "115",
"source": "Chloramphenicol Action Pathway",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "116",
"source": "Clarithromycin Action Pathway",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "117",
"source": "Clindamycin Action Pathway",
"target": "Clomocycline Action Pathway" 
},
{
 "id": "118",
"source": "Amino acid transport across the plasma membrane",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "119",
"source": "Amino acid transport defects (IEMs)",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "120",
"source": "Transcription/Translation",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "121",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "122",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "123",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "124",
"source": "Amikacin Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "125",
"source": "Arbekacin Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "126",
"source": "Azithromycin Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "127",
"source": "Chloramphenicol Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "128",
"source": "Clarithromycin Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "129",
"source": "Clindamycin Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "130",
"source": "Clomocycline Action Pathway",
"target": "Demeclocycline Action Pathway" 
},
{
 "id": "131",
"source": "Amino acid transport across the plasma membrane",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "132",
"source": "Amino acid transport defects (IEMs)",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "133",
"source": "Transcription/Translation",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "134",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "135",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "136",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "137",
"source": "Amikacin Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "138",
"source": "Arbekacin Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "139",
"source": "Azithromycin Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "140",
"source": "Chloramphenicol Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "141",
"source": "Clarithromycin Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "142",
"source": "Clindamycin Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "143",
"source": "Clomocycline Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "144",
"source": "Demeclocycline Action Pathway",
"target": "Doxycycline Action Pathway" 
},
{
 "id": "145",
"source": "Amino acid transport across the plasma membrane",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "146",
"source": "Amino acid transport defects (IEMs)",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "147",
"source": "Transcription/Translation",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "148",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "149",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "150",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "151",
"source": "Amikacin Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "152",
"source": "Arbekacin Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "153",
"source": "Azithromycin Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "154",
"source": "Chloramphenicol Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "155",
"source": "Clarithromycin Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "156",
"source": "Clindamycin Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "157",
"source": "Clomocycline Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "158",
"source": "Demeclocycline Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "159",
"source": "Doxycycline Action Pathway",
"target": "Erythromycin Action Pathway" 
},
{
 "id": "160",
"source": "Amino acid transport across the plasma membrane",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "161",
"source": "Amino acid transport defects (IEMs)",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "162",
"source": "Transcription/Translation",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "163",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "164",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "165",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "166",
"source": "Amikacin Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "167",
"source": "Arbekacin Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "168",
"source": "Azithromycin Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "169",
"source": "Chloramphenicol Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "170",
"source": "Clarithromycin Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "171",
"source": "Clindamycin Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "172",
"source": "Clomocycline Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "173",
"source": "Demeclocycline Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "174",
"source": "Doxycycline Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "175",
"source": "Erythromycin Action Pathway",
"target": "Gentamicin Action Pathway" 
},
{
 "id": "176",
"source": "Amino acid transport across the plasma membrane",
"target": "Josamycin Action Pathway" 
},
{
 "id": "177",
"source": "Amino acid transport defects (IEMs)",
"target": "Josamycin Action Pathway" 
},
{
 "id": "178",
"source": "Transcription/Translation",
"target": "Josamycin Action Pathway" 
},
{
 "id": "179",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Josamycin Action Pathway" 
},
{
 "id": "180",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Josamycin Action Pathway" 
},
{
 "id": "181",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Josamycin Action Pathway" 
},
{
 "id": "182",
"source": "Amikacin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "183",
"source": "Arbekacin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "184",
"source": "Azithromycin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "185",
"source": "Chloramphenicol Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "186",
"source": "Clarithromycin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "187",
"source": "Clindamycin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "188",
"source": "Clomocycline Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "189",
"source": "Demeclocycline Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "190",
"source": "Doxycycline Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "191",
"source": "Erythromycin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "192",
"source": "Gentamicin Action Pathway",
"target": "Josamycin Action Pathway" 
},
{
 "id": "193",
"source": "Amino acid transport across the plasma membrane",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "194",
"source": "Amino acid transport defects (IEMs)",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "195",
"source": "Transcription/Translation",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "196",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "197",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "198",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "199",
"source": "Amikacin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "200",
"source": "Arbekacin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "201",
"source": "Azithromycin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "202",
"source": "Chloramphenicol Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "203",
"source": "Clarithromycin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "204",
"source": "Clindamycin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "205",
"source": "Clomocycline Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "206",
"source": "Demeclocycline Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "207",
"source": "Doxycycline Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "208",
"source": "Erythromycin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "209",
"source": "Gentamicin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "210",
"source": "Josamycin Action Pathway",
"target": "Kanamycin Action Pathway" 
},
{
 "id": "211",
"source": "Amino acid transport across the plasma membrane",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "212",
"source": "Amino acid transport defects (IEMs)",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "213",
"source": "Transcription/Translation",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "214",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "215",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "216",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "217",
"source": "Amikacin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "218",
"source": "Arbekacin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "219",
"source": "Azithromycin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "220",
"source": "Chloramphenicol Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "221",
"source": "Clarithromycin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "222",
"source": "Clindamycin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "223",
"source": "Clomocycline Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "224",
"source": "Demeclocycline Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "225",
"source": "Doxycycline Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "226",
"source": "Erythromycin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "227",
"source": "Gentamicin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "228",
"source": "Josamycin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "229",
"source": "Kanamycin Action Pathway",
"target": "Lincomycin Action Pathway" 
},
{
 "id": "230",
"source": "Amino acid transport across the plasma membrane",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "231",
"source": "Amino acid transport defects (IEMs)",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "232",
"source": "Transcription/Translation",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "233",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "234",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "235",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "236",
"source": "Amikacin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "237",
"source": "Arbekacin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "238",
"source": "Azithromycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "239",
"source": "Chloramphenicol Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "240",
"source": "Clarithromycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "241",
"source": "Clindamycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "242",
"source": "Clomocycline Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "243",
"source": "Demeclocycline Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "244",
"source": "Doxycycline Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "245",
"source": "Erythromycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "246",
"source": "Gentamicin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "247",
"source": "Josamycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "248",
"source": "Kanamycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "249",
"source": "Lincomycin Action Pathway",
"target": "Lymecycline Action Pathway" 
},
{
 "id": "250",
"source": "Amino acid transport across the plasma membrane",
"target": "Methacycline Action Pathway" 
},
{
 "id": "251",
"source": "Amino acid transport defects (IEMs)",
"target": "Methacycline Action Pathway" 
},
{
 "id": "252",
"source": "Transcription/Translation",
"target": "Methacycline Action Pathway" 
},
{
 "id": "253",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Methacycline Action Pathway" 
},
{
 "id": "254",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Methacycline Action Pathway" 
},
{
 "id": "255",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Methacycline Action Pathway" 
},
{
 "id": "256",
"source": "Amikacin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "257",
"source": "Arbekacin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "258",
"source": "Azithromycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "259",
"source": "Chloramphenicol Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "260",
"source": "Clarithromycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "261",
"source": "Clindamycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "262",
"source": "Clomocycline Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "263",
"source": "Demeclocycline Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "264",
"source": "Doxycycline Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "265",
"source": "Erythromycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "266",
"source": "Gentamicin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "267",
"source": "Josamycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "268",
"source": "Kanamycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "269",
"source": "Lincomycin Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "270",
"source": "Lymecycline Action Pathway",
"target": "Methacycline Action Pathway" 
},
{
 "id": "271",
"source": "Amino acid transport across the plasma membrane",
"target": "Minocycline Action Pathway" 
},
{
 "id": "272",
"source": "Amino acid transport defects (IEMs)",
"target": "Minocycline Action Pathway" 
},
{
 "id": "273",
"source": "Transcription/Translation",
"target": "Minocycline Action Pathway" 
},
{
 "id": "274",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Minocycline Action Pathway" 
},
{
 "id": "275",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Minocycline Action Pathway" 
},
{
 "id": "276",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Minocycline Action Pathway" 
},
{
 "id": "277",
"source": "Amikacin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "278",
"source": "Arbekacin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "279",
"source": "Azithromycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "280",
"source": "Chloramphenicol Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "281",
"source": "Clarithromycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "282",
"source": "Clindamycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "283",
"source": "Clomocycline Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "284",
"source": "Demeclocycline Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "285",
"source": "Doxycycline Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "286",
"source": "Erythromycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "287",
"source": "Gentamicin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "288",
"source": "Josamycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "289",
"source": "Kanamycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "290",
"source": "Lincomycin Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "291",
"source": "Lymecycline Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "292",
"source": "Methacycline Action Pathway",
"target": "Minocycline Action Pathway" 
},
{
 "id": "293",
"source": "Amino acid transport across the plasma membrane",
"target": "Neomycin Action Pathway" 
},
{
 "id": "294",
"source": "Amino acid transport defects (IEMs)",
"target": "Neomycin Action Pathway" 
},
{
 "id": "295",
"source": "Transcription/Translation",
"target": "Neomycin Action Pathway" 
},
{
 "id": "296",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Neomycin Action Pathway" 
},
{
 "id": "297",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Neomycin Action Pathway" 
},
{
 "id": "298",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Neomycin Action Pathway" 
},
{
 "id": "299",
"source": "Amikacin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "300",
"source": "Arbekacin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "301",
"source": "Azithromycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "302",
"source": "Chloramphenicol Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "303",
"source": "Clarithromycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "304",
"source": "Clindamycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "305",
"source": "Clomocycline Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "306",
"source": "Demeclocycline Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "307",
"source": "Doxycycline Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "308",
"source": "Erythromycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "309",
"source": "Gentamicin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "310",
"source": "Josamycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "311",
"source": "Kanamycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "312",
"source": "Lincomycin Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "313",
"source": "Lymecycline Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "314",
"source": "Methacycline Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "315",
"source": "Minocycline Action Pathway",
"target": "Neomycin Action Pathway" 
},
{
 "id": "316",
"source": "Amino acid transport across the plasma membrane",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "317",
"source": "Amino acid transport defects (IEMs)",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "318",
"source": "Transcription/Translation",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "319",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "320",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "321",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "322",
"source": "Amikacin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "323",
"source": "Arbekacin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "324",
"source": "Azithromycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "325",
"source": "Chloramphenicol Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "326",
"source": "Clarithromycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "327",
"source": "Clindamycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "328",
"source": "Clomocycline Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "329",
"source": "Demeclocycline Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "330",
"source": "Doxycycline Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "331",
"source": "Erythromycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "332",
"source": "Gentamicin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "333",
"source": "Josamycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "334",
"source": "Kanamycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "335",
"source": "Lincomycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "336",
"source": "Lymecycline Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "337",
"source": "Methacycline Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "338",
"source": "Minocycline Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "339",
"source": "Neomycin Action Pathway",
"target": "Netilmicin Action Pathway" 
},
{
 "id": "340",
"source": "Amino acid transport across the plasma membrane",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "341",
"source": "Amino acid transport defects (IEMs)",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "342",
"source": "Transcription/Translation",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "343",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "344",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "345",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "346",
"source": "Amikacin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "347",
"source": "Arbekacin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "348",
"source": "Azithromycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "349",
"source": "Chloramphenicol Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "350",
"source": "Clarithromycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "351",
"source": "Clindamycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "352",
"source": "Clomocycline Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "353",
"source": "Demeclocycline Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "354",
"source": "Doxycycline Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "355",
"source": "Erythromycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "356",
"source": "Gentamicin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "357",
"source": "Josamycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "358",
"source": "Kanamycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "359",
"source": "Lincomycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "360",
"source": "Lymecycline Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "361",
"source": "Methacycline Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "362",
"source": "Minocycline Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "363",
"source": "Neomycin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "364",
"source": "Netilmicin Action Pathway",
"target": "Oxytetracycline Action Pathway" 
},
{
 "id": "365",
"source": "Amino acid transport across the plasma membrane",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "366",
"source": "Amino acid transport defects (IEMs)",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "367",
"source": "Transcription/Translation",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "368",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "369",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "370",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "371",
"source": "Amikacin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "372",
"source": "Arbekacin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "373",
"source": "Azithromycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "374",
"source": "Chloramphenicol Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "375",
"source": "Clarithromycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "376",
"source": "Clindamycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "377",
"source": "Clomocycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "378",
"source": "Demeclocycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "379",
"source": "Doxycycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "380",
"source": "Erythromycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "381",
"source": "Gentamicin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "382",
"source": "Josamycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "383",
"source": "Kanamycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "384",
"source": "Lincomycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "385",
"source": "Lymecycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "386",
"source": "Methacycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "387",
"source": "Minocycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "388",
"source": "Neomycin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "389",
"source": "Netilmicin Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "390",
"source": "Oxytetracycline Action Pathway",
"target": "Paromomycin Action Pathway" 
},
{
 "id": "391",
"source": "Amino acid transport across the plasma membrane",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "392",
"source": "Amino acid transport defects (IEMs)",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "393",
"source": "Transcription/Translation",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "394",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "395",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "396",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "397",
"source": "Amikacin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "398",
"source": "Arbekacin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "399",
"source": "Azithromycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "400",
"source": "Chloramphenicol Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "401",
"source": "Clarithromycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "402",
"source": "Clindamycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "403",
"source": "Clomocycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "404",
"source": "Demeclocycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "405",
"source": "Doxycycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "406",
"source": "Erythromycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "407",
"source": "Gentamicin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "408",
"source": "Josamycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "409",
"source": "Kanamycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "410",
"source": "Lincomycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "411",
"source": "Lymecycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "412",
"source": "Methacycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "413",
"source": "Minocycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "414",
"source": "Neomycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "415",
"source": "Netilmicin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "416",
"source": "Oxytetracycline Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "417",
"source": "Paromomycin Action Pathway",
"target": "Rolitetracycline Action Pathway" 
},
{
 "id": "418",
"source": "Amino acid transport across the plasma membrane",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "419",
"source": "Amino acid transport defects (IEMs)",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "420",
"source": "Transcription/Translation",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "421",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "422",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "423",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "424",
"source": "Amikacin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "425",
"source": "Arbekacin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "426",
"source": "Azithromycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "427",
"source": "Chloramphenicol Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "428",
"source": "Clarithromycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "429",
"source": "Clindamycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "430",
"source": "Clomocycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "431",
"source": "Demeclocycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "432",
"source": "Doxycycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "433",
"source": "Erythromycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "434",
"source": "Gentamicin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "435",
"source": "Josamycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "436",
"source": "Kanamycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "437",
"source": "Lincomycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "438",
"source": "Lymecycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "439",
"source": "Methacycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "440",
"source": "Minocycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "441",
"source": "Neomycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "442",
"source": "Netilmicin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "443",
"source": "Oxytetracycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "444",
"source": "Paromomycin Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "445",
"source": "Rolitetracycline Action Pathway",
"target": "Roxithromycin Action Pathway" 
},
{
 "id": "446",
"source": "Amino acid transport across the plasma membrane",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "447",
"source": "Amino acid transport defects (IEMs)",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "448",
"source": "Transcription/Translation",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "449",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "450",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "451",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "452",
"source": "Amikacin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "453",
"source": "Arbekacin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "454",
"source": "Azithromycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "455",
"source": "Chloramphenicol Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "456",
"source": "Clarithromycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "457",
"source": "Clindamycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "458",
"source": "Clomocycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "459",
"source": "Demeclocycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "460",
"source": "Doxycycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "461",
"source": "Erythromycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "462",
"source": "Gentamicin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "463",
"source": "Josamycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "464",
"source": "Kanamycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "465",
"source": "Lincomycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "466",
"source": "Lymecycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "467",
"source": "Methacycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "468",
"source": "Minocycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "469",
"source": "Neomycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "470",
"source": "Netilmicin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "471",
"source": "Oxytetracycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "472",
"source": "Paromomycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "473",
"source": "Rolitetracycline Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "474",
"source": "Roxithromycin Action Pathway",
"target": "Spectinomycin Action Pathway" 
},
{
 "id": "475",
"source": "Amino acid transport across the plasma membrane",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "476",
"source": "Amino acid transport defects (IEMs)",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "477",
"source": "Transcription/Translation",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "478",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "479",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "480",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "481",
"source": "Amikacin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "482",
"source": "Arbekacin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "483",
"source": "Azithromycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "484",
"source": "Chloramphenicol Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "485",
"source": "Clarithromycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "486",
"source": "Clindamycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "487",
"source": "Clomocycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "488",
"source": "Demeclocycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "489",
"source": "Doxycycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "490",
"source": "Erythromycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "491",
"source": "Gentamicin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "492",
"source": "Josamycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "493",
"source": "Kanamycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "494",
"source": "Lincomycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "495",
"source": "Lymecycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "496",
"source": "Methacycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "497",
"source": "Minocycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "498",
"source": "Neomycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "499",
"source": "Netilmicin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "500",
"source": "Oxytetracycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "501",
"source": "Paromomycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "502",
"source": "Rolitetracycline Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "503",
"source": "Roxithromycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "504",
"source": "Spectinomycin Action Pathway",
"target": "Streptomycin Action Pathway" 
},
{
 "id": "505",
"source": "Amino acid transport across the plasma membrane",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "506",
"source": "Amino acid transport defects (IEMs)",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "507",
"source": "Transcription/Translation",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "508",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "509",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "510",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "511",
"source": "Amikacin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "512",
"source": "Arbekacin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "513",
"source": "Azithromycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "514",
"source": "Chloramphenicol Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "515",
"source": "Clarithromycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "516",
"source": "Clindamycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "517",
"source": "Clomocycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "518",
"source": "Demeclocycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "519",
"source": "Doxycycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "520",
"source": "Erythromycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "521",
"source": "Gentamicin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "522",
"source": "Josamycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "523",
"source": "Kanamycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "524",
"source": "Lincomycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "525",
"source": "Lymecycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "526",
"source": "Methacycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "527",
"source": "Minocycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "528",
"source": "Neomycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "529",
"source": "Netilmicin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "530",
"source": "Oxytetracycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "531",
"source": "Paromomycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "532",
"source": "Rolitetracycline Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "533",
"source": "Roxithromycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "534",
"source": "Spectinomycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "535",
"source": "Streptomycin Action Pathway",
"target": "Telithromycin Action Pathway" 
},
{
 "id": "536",
"source": "Amino acid transport across the plasma membrane",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "537",
"source": "Amino acid transport defects (IEMs)",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "538",
"source": "Transcription/Translation",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "539",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "540",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "541",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "542",
"source": "Amikacin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "543",
"source": "Arbekacin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "544",
"source": "Azithromycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "545",
"source": "Chloramphenicol Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "546",
"source": "Clarithromycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "547",
"source": "Clindamycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "548",
"source": "Clomocycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "549",
"source": "Demeclocycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "550",
"source": "Doxycycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "551",
"source": "Erythromycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "552",
"source": "Gentamicin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "553",
"source": "Josamycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "554",
"source": "Kanamycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "555",
"source": "Lincomycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "556",
"source": "Lymecycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "557",
"source": "Methacycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "558",
"source": "Minocycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "559",
"source": "Neomycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "560",
"source": "Netilmicin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "561",
"source": "Oxytetracycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "562",
"source": "Paromomycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "563",
"source": "Rolitetracycline Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "564",
"source": "Roxithromycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "565",
"source": "Spectinomycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "566",
"source": "Streptomycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "567",
"source": "Telithromycin Action Pathway",
"target": "Tetracycline Action Pathway" 
},
{
 "id": "568",
"source": "Amino acid transport across the plasma membrane",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "569",
"source": "Amino acid transport defects (IEMs)",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "570",
"source": "Transcription/Translation",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "571",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "572",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "573",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "574",
"source": "Amikacin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "575",
"source": "Arbekacin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "576",
"source": "Azithromycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "577",
"source": "Chloramphenicol Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "578",
"source": "Clarithromycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "579",
"source": "Clindamycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "580",
"source": "Clomocycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "581",
"source": "Demeclocycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "582",
"source": "Doxycycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "583",
"source": "Erythromycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "584",
"source": "Gentamicin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "585",
"source": "Josamycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "586",
"source": "Kanamycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "587",
"source": "Lincomycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "588",
"source": "Lymecycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "589",
"source": "Methacycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "590",
"source": "Minocycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "591",
"source": "Neomycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "592",
"source": "Netilmicin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "593",
"source": "Oxytetracycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "594",
"source": "Paromomycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "595",
"source": "Rolitetracycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "596",
"source": "Roxithromycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "597",
"source": "Spectinomycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "598",
"source": "Streptomycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "599",
"source": "Telithromycin Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "600",
"source": "Tetracycline Action Pathway",
"target": "Tigecycline Action Pathway" 
},
{
 "id": "601",
"source": "Amino acid transport across the plasma membrane",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "602",
"source": "Amino acid transport defects (IEMs)",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "603",
"source": "Transcription/Translation",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "604",
"source": "Na+/Cl- dependent neurotransmitter transporters",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "605",
"source": "Variant SLC6A14 may confer susceptibility towards obesity",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "606",
"source": "Defective SLC6A19 causes Hartnup disorder (HND)",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "607",
"source": "Amikacin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "608",
"source": "Arbekacin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "609",
"source": "Azithromycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "610",
"source": "Chloramphenicol Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "611",
"source": "Clarithromycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "612",
"source": "Clindamycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "613",
"source": "Clomocycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "614",
"source": "Demeclocycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "615",
"source": "Doxycycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "616",
"source": "Erythromycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "617",
"source": "Gentamicin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "618",
"source": "Josamycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "619",
"source": "Kanamycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "620",
"source": "Lincomycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "621",
"source": "Lymecycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "622",
"source": "Methacycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "623",
"source": "Minocycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "624",
"source": "Neomycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "625",
"source": "Netilmicin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "626",
"source": "Oxytetracycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "627",
"source": "Paromomycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "628",
"source": "Rolitetracycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "629",
"source": "Roxithromycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "630",
"source": "Spectinomycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "631",
"source": "Streptomycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "632",
"source": "Telithromycin Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "633",
"source": "Tetracycline Action Pathway",
"target": "Tobramycin Action Pathway" 
},
{
 "id": "634",
"source": "Tigecycline Action Pathway",
"target": "Tobramycin Action Pathway" 
} ] 
}